Author:
Giordano Sharon H.,Duan Zhigang,Kuo Yong-Fang,Hortobagyi Gabriel N.,Freeman Jean,Goodwin James S.
Publisher
Oxford University Press (OUP)
Reference34 articles.
1. Jackevicius CA, Anderson GM, Leiter L, Tu JV. Use of the statins in patients after acute myocardial infarction: does evidence change practice? Arch Intern Med2001 ; 161 : 183 –8.
2. Stafford RS, Furberg CD, Finkelstein SN, Cockburn IM, Alehegn T, Ma J. Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996–2002. JAMA2004 ; 291 : 54 –62.
3. Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med2004 ; 140 : 184 –8.
4. Henderson IC, Berry D, Demetri GD, Cirrincione C, Goldstein LJ, Martino S, et al. Improved disease-free and overall survival from the addition of sequential paclitaxel but not from the escalation of doxorubicin dose in the adjuvant chemotherapy of patients with node-positive primary breast cancer. Proc ASCO1998 ; 17 : 101a .
5. Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, et al. Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol2003 ; 21 : 976 –83.